Which meningococcal vaccine is specifically recommended for individuals who are 9 months old?

The meningococcal vaccine specifically recommended for individuals who are 9 months old is Menactra. This vaccine is formulated to protect against multiple serogroups of Neisseria meningitidis bacteria, particularly the A, C, W, and Y serogroups. It is typically administered as part of routine childhood vaccinations and can be given to adolescents and young adults as well.

Menactra is licensed for use in children as young as 9 months, making it suitable for infants who are within that age bracket. Understanding the specific indications for each meningococcal vaccine is crucial for effective immunization practices.

Other vaccines listed, such as MenQuadfi, Menveo, and MenB, target different age groups or specific strains of meningococcal disease but do not include the 9-month-old age recommendation that Menactra does.